Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, August 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Kemwell Adds Lyophilization Capability
Saturday, March 22, 2014
Addition of the new freeze drying capability sets the Company on a course to expand business from both new and existing customers.

Catalent Launches ADVASEPT™ Advanced Aseptic Technology
Saturday, March 15, 2014
New technology for glass-free delivery of injectable drugs.

Lab Relocation Specialist Expands Turnkey Solution
Friday, March 07, 2014
Specialist laboratory relocation expert, Andrew Porter Limited, has further expanded its service portfolio.

Almac Adds New Blistering Technology at US Facility
Friday, February 28, 2014
Simple solutions to bridge the gap between clinical and commercial packaging.

Sapio Sciences Announces Exemplar LIMS for Clinical and Research NGS Labs
Tuesday, February 25, 2014
Purpose-built system handles the sample tracking and processing needs of clinical or research laboratories

Irisbiosciences a New Player in 3D Cell Culture
Friday, February 14, 2014
Irisbiosciences is focused on the development, manufacturing and marketing of products for bio-/pharmaceutical research and development, namely 3D cell culture products, tissue models and human & stem cells for in-vitro experimentation.

Intelsius Enhances Patient Safety Products
Thursday, February 13, 2014
Company announces enhancement to ThermoTrek™ range of solutions.

GCT Selects CRO Starter Kit™ PSA Platform by Flex Databases
Thursday, February 13, 2014
CRO Starter Kit™ provide increased efficiency and speed in running clinical research projects.

Crown Bioscience to Showcase Novel “in life” Platforms for Oncology
Tuesday, February 11, 2014
Company will highlight its expertise in Oncology Drug Discovery at AACR 2014.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 292
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv